BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia
- Author(s)
- Karsa, M; Karsa, A; Spurling, D; Xiao, L; Ronca, E; Bongers, A; Gao, W; Gifford, AJ; El-Ayoubi, A; Cheung, LC; Kotecha, RS; Lock, RB; Teh, CE; Lessene, G; Norris, MD; Wei, A; Haber, M; Henderson, MJ; Moujalled, DM; Somers, K;
- Journal Title
- British Journal of Haematology
- Publication Type
- Jun 5
- Publisher
- Wiley
- Keywords
- Bcl‐2; KMT2A‐rearranged; Mcl1; leukaemia; venetoclax
- Research Division(s)
- Immunology; New Medicines and Diagnostics; Blood Cells and Blood Cancer
- PubMed ID
- 42246204
- Publisher's Version
- https://doi.org/10.1111/bjh.70598
- Open Access at Publisher's Site
https://doi.org/10.1111/bjh.70598- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-06-10 01:51:14
Last Modified: 2026-06-10 01:55:06